View in EDS

GOG-3039: A phase II trial of abemaciclib plus letrozole in recurrent or persistent endometrioid endometrial carcinoma (NCT04393285).

Saved in:
Bibliographic Details
Title: GOG-3039: A phase II trial of abemaciclib plus letrozole in recurrent or persistent endometrioid endometrial carcinoma (NCT04393285).
Authors: Huang, Marilyn1 (AUTHOR), Huang, Gloria2 (AUTHOR), Pearson, J. Matt3 (AUTHOR), Gill, Sarah4 (AUTHOR), Holloway, Robert5 (AUTHOR), Moroney, John6 (AUTHOR), Werner, Theresa7 (AUTHOR), Leiser, Aliza8 (AUTHOR), Paraghamian, Sarah9 (AUTHOR), Gold, Michael10 (AUTHOR), Ring, Kari1 (AUTHOR), Pfaendler, Krista11 (AUTHOR), Cottrill, Hope12 (AUTHOR), Cunningham, Mary13 (AUTHOR), Lewin, Sharyn14 (AUTHOR), Edelson, Mitchell15 (AUTHOR), Herzog, Thomas16 (AUTHOR), Slomovitz, Brian17 (AUTHOR)
Source: Gynecologic Oncology. May2026:Supplement, Vol. 208, pS31-S32. 2p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2026.01.053